Walleye Capital LLC Moderna, Inc. Call Options Transaction History

Walleye Capital LLC

11 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2024 Aug 14, 2024	SELL	$101.21 - $166.61 $3.08 Million - $5.06 Million	-30,400 Reduced 25.59%	88,400 $10.5 Million
Q1 2024 May 15, 2024	BUY	$85.37 - $115.44 $5.77 Million - $7.8 Million	67,600 Added 132.03%	118,800 $12.7 Million
Q4 2023 Feb 14, 2024	BUY	$69.51 - $104.43 $291,942 - $438,606	4,200 Added 8.94%	51,200 $5.09 Million
Q3 2023 Nov 14, 2023	BUY	$96.41 - $126.61 $1.82 Million - $2.39 Million	18,900 Added 67.26%	47,000 $4.85 Million
Q2 2023 Aug 14, 2023	BUY	$118.5 - $160.53 $2.29 Million - $3.1 Million	19,300 Added 219.32%	28,100 $3.41 Million
Q1 2023 May 15, 2023	SELL	$135.66 - $197.02 $556,206 - $807,782	-4,100 Reduced 31.78%	8,800 $1.35 Million
Q4 2022 Feb 14, 2023	BUY	$118.38 - $210.04 $295,950 - $525,100	2,500 Added 24.04%	12,900 $2.32 Million
Q3 2022 Nov 14, 2022	BUY	$118.07 - $194.18 $1.23 Million - $2.02 Million	10,400 New	10,400 $1.23 Million
Q2 2020 Aug 14, 2020	SELL	$29.67 - $80.0 $712,080 - $1.92 Million	-24,000 Closed	0 $0
Q1 2020 May 15, 2020	SELL	$17.78 - $31.58 $501,396 - $890,556	-28,200 Reduced 54.02%	24,000 $719,000
Q4 2019 Feb 14, 2020	BUY	$13.93 - $21.28 $727,146 - $1.11 Million	52,200 New	52,200 $1.02 Million

1,113

241M

9.26M

12.1M

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $25.7B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

Get notified when there are updates to the investment portfolio of Walleye Capital LLC, based on Form 13F filings with the SEC.

Stay updated on Walleye Capital LLC with notifications on news.